During the variant calling process, we identified pathogenic mutations in four of the ten tumor samples, all of them present in BRCA1: a frame-shift insertion (c.5263_5264insC) and two nonsense mutation (c.628C>T and c.5251C>T). This evidence concerns the gene BRCA1 and neoplasm.